As of 2026, neither CJC-1295 nor Ipamorelin is approved by any regulatory authority (FDA, EMA, ANSM)
Thats why we ended the partnership. In a post on X, Hims Chief Executive Andrew Dudum called the Novo executives comments misleading. He said Novo had been pressuring Hims to steer patients to Wegovy regardless of whether it was clinically best for patients. We refuse to be strong-armed, he said, adding that Hims will continue to offer a range of treatments, including Wegovy. Hims shares tumbled 35% in New York Monday the most ever as analysts said the withdrawal would leave the telehealth company without an attractive obesity profit stream
Hypertension 69, 902909 10.1161/HYPERTENSIONAHA.116.08964 [DOI] [PMC free article] [PubMed] [Google Scholar] 217.Huang C.W
Medication Alone Clinics offering semaglutide injections as part of a complete weight management program may have higher upfront costs but provide added value through personalized care, support, and testing
Methods 9, 23572360
Reddy's Laboratories, making Canada the first G7 country to approve a generic version of semaglutide [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]